These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 24038408)

  • 21. Potential benefits of scanned intensity-modulated proton therapy versus advanced photon therapy with regard to sparing of the salivary glands in oropharyngeal cancer.
    van de Water TA; Lomax AJ; Bijl HP; de Jong ME; Schilstra C; Hug EB; Langendijk JA
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1216-24. PubMed ID: 20732761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intensity-modulated radiotherapy: is xerostomia still prevalent?
    Chambers MS; Garden AS; Rosenthal D; Ahamad A; Schwartz DL; Blanco AI; Chao KS; Morrison WH; Ang KK; Weber RS
    Curr Oncol Rep; 2005 Mar; 7(2):131-6. PubMed ID: 15717947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intensity-modulated radiation therapy and xerostomia.
    Chambers MS; Weber RS; Garden AS
    J Calif Dent Assoc; 2006 Sep; 34(9):743-8. PubMed ID: 17022299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parotid gland mean dose as a xerostomia predictor in low-dose domains.
    Gabryś HS; Buettner F; Sterzing F; Hauswald H; Bangert M
    Acta Oncol; 2017 Sep; 56(9):1197-1203. PubMed ID: 28502238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reducing the risk of xerostomia and mandibular osteoradionecrosis: the potential benefits of intensity modulated radiotherapy in advanced oral cavity carcinoma.
    Ahmed M; Hansen VN; Harrington KJ; Nutting CM
    Med Dosim; 2009; 34(3):217-24. PubMed ID: 19647632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contribution of submandibular gland and swallowing structure sparing to post-radiation therapy PEG dependence in oropharynx cancer patients treated with split-neck IMRT technique.
    Gensheimer MF; Nyflot M; Laramore GE; Liao JJ; Parvathaneni U
    Radiat Oncol; 2016 Nov; 11(1):151. PubMed ID: 27846899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of intensity-modulated radiation therapy and concomitant boost radiotherapy in the setting of concurrent chemotherapy for locally advanced oropharyngeal carcinoma.
    Lee NY; de Arruda FF; Puri DR; Wolden SL; Narayana A; Mechalakos J; Venkatraman ES; Kraus D; Shaha A; Shah JP; Pfister DG; Zelefsky MJ
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):966-74. PubMed ID: 17145527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intensity-modulated radiotherapy significantly reduces xerostomia compared with conventional radiotherapy.
    Braam PM; Terhaard CH; Roesink JM; Raaijmakers CP
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):975-80. PubMed ID: 16965864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program.
    Vergeer MR; Doornaert PA; Rietveld DH; Leemans CR; Slotman BJ; Langendijk JA
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):1-8. PubMed ID: 19111400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IMRT with simultaneous integrated boost and concurrent chemotherapy for nasopharyngeal cancer: plan evaluation and treatment outcome.
    Kim JW; Cho JH; Keum KC; Kim JH; Kim GE; Lee JY; Kim SK; Lee CG
    Jpn J Clin Oncol; 2012 Dec; 42(12):1152-60. PubMed ID: 23077243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience.
    Kam MK; Teo PM; Chau RM; Cheung KY; Choi PH; Kwan WH; Leung SF; Zee B; Chan AT
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1440-50. PubMed ID: 15590175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parotid gland shrinkage during IMRT predicts the time to Xerostomia resolution.
    Sanguineti G; Ricchetti F; Wu B; McNutt T; Fiorino C
    Radiat Oncol; 2015 Jan; 10():19. PubMed ID: 25595326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment plan comparison between helical tomotherapy and MLC-based IMRT using radiobiological measures.
    Mavroidis P; Ferreira BC; Shi C; Lind BK; Papanikolaou N
    Phys Med Biol; 2007 Jul; 52(13):3817-36. PubMed ID: 17664579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Salivary gland tumors treated with adjuvant intensity-modulated radiotherapy with or without concurrent chemotherapy.
    Schoenfeld JD; Sher DJ; Norris CM; Haddad RI; Posner MR; Balboni TA; Tishler RB
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):308-14. PubMed ID: 21075557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disease-control rates following intensity-modulated radiation therapy for small primary oropharyngeal carcinoma.
    Garden AS; Morrison WH; Wong PF; Tung SS; Rosenthal DI; Dong L; Mason B; Perkins GH; Ang KK
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):438-44. PubMed ID: 17141972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aichi cancer center initial experience of intensity modulated radiation therapy for nasopharyngeal cancer using helical tomotherapy.
    Kodaira T; Tomita N; Tachibana H; Nakamura T; Nakahara R; Inokuchi H; Fuwa N
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1129-34. PubMed ID: 18922651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The QUANTEC criteria for parotid gland dose and their efficacy to prevent moderate to severe patient-rated xerostomia.
    Beetz I; Steenbakkers RJ; Chouvalova O; Leemans CR; Doornaert P; van der Laan BF; Christianen ME; Vissink A; Bijl HP; van Luijk P; Langendijk JA
    Acta Oncol; 2014 May; 53(5):597-604. PubMed ID: 23998646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simultaneous integrated boost using intensity-modulated radiotherapy compared with conventional radiotherapy in patients treated with concurrent carboplatin and 5-fluorouracil for locally advanced oropharyngeal carcinoma.
    Clavel S; Nguyen DH; Fortin B; Després P; Khaouam N; Donath D; Soulières D; Guertin L; Nguyen-Tan PF
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):582-9. PubMed ID: 21277695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volume.
    Chao KS; Ozyigit G; Blanco AI; Thorstad WL; Deasy JO; Haughey BH; Spector GJ; Sessions DG
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):43-50. PubMed ID: 15093897
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intensity-modulated versus conventional radiation therapy for oropharyngeal carcinoma: long-term dysphagia and tumor control outcomes.
    McBride SM; Parambi RJ; Jang JW; Goldsmith T; Busse PM; Chan AW
    Head Neck; 2014 Apr; 36(4):492-8. PubMed ID: 23729221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.